"Das Universitätsklinikum des Saarlandes (UKS) ist mit 30 Kliniken und 20 Instituten das medizinische Hochleistungszentrum der Großregion und bietet international vernetzte Spitzenforschung. Jedes Jahr werden über 50.000 Patienten stationär und über 200.000 ambulant versorgt. Als einer der größten Arbeitgeber und Ausbilder des Saarlandes beschäftigen wir über 5 000 Beschäftigte, darunter u. a. 2 000 Pflegekräfte, rund 600 Ärztinnen und Ärzte und über 600 Auszubildende. An der Medizinischen Fakultät des Saarlandes studieren rund 2.000 Studentinnen und Studenten der Fächer Human- und Zahnmedizin, Human- und Molekularbiologie sowie Bioinformatik."

During the past decade, Department of Internal Medicine I, University Hospital of Saarland conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Internal Medicine I, University Hospital of Saarland" #1 collaborator was "German Federal Ministry of Education and Research" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Department of Internal Medicine I, University Hospital of Saarland" are "Acute Myeloid Leukemia" (2 trials), "Acute Myeloid Leukemia (AML)" (1 trials) and "Leukemia, Myeloid, Acute" (1 trials). Many other conditions were trialed in "Department of Internal Medicine I, University Hospital of Saarland" in a lesser frequency.

Most popular intervention types in "Department of Internal Medicine I, University Hospital of Saarland" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Cytarabine" (4 trials), "All-trans retinoic acid" (2 trials), "Etoposide" (2 trials), "Idarubicin" (2 trials) and "Mitoxantrone" (2 trials). Other intervention names were less common.

The vast majority of trials in "Department of Internal Medicine I, University Hospital of Saarland" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Department of Internal Medicine I, University Hospital of Saarland". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Department of Internal Medicine I, University Hospital of Saarland, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Department of Internal Medicine I, University Hospital of Saarland, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".